Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38373
CAS Number:
138982-67-9
Chlorhydrate de ziprasidone monohydraté
Purity:
≥ 98 % (HPLC)
Synonym(s):
Chlorhydrate de 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-pipérazinyl]éthyl]-6-chloro-1,3-dihydro-2 H -indol-2-one monohydraté
Documents
$56.99 /50 mg
Taille
Request Bulk Quote
Informations sur le produit

Ziprasidone hydrochloride monohydrate is a potent atypical antipsychotic primarily used in the treatment of schizophrenia and bipolar disorder. This compound is recognized for its ability to effectively manage symptoms while minimizing side effects commonly associated with traditional antipsychotics. The unique structure of Ziprasidone allows it to act on multiple neurotransmitter systems, including serotonin and dopamine receptors, making it a versatile option for mental health professionals.

In clinical settings, Ziprasidone hydrochloride monohydrate has demonstrated efficacy in reducing both positive and negative symptoms of schizophrenia, providing a comprehensive approach to patient care. Its favorable pharmacokinetic profile, including a lower risk of weight gain compared to other antipsychotics, enhances its appeal among healthcare providers. Additionally, ongoing research into its potential applications in treating other psychiatric disorders underscores its relevance in modern therapeutic strategies.

Numéro CAS 
138982-67-9
Formule moléculaire
C21H21ClN4OS · HCl · H2O
Poids moléculaire 
467.41
Informations générales
Numéro CAS 
138982-67-9
Formule moléculaire
C21H21ClN4OS · HCl · H2O
Poids moléculaire 
467.41
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Ziprasidone hydrochloride monohydrate is widely utilized in research focused on

  • Treatment of Schizophrenia: This compound is primarily used as an antipsychotic medication, helping to manage symptoms of schizophrenia effectively, which can enhance the quality of life for patients.
  • Bipolar Disorder Management: It is also prescribed for treating acute manic or mixed episodes associated with bipolar disorder, providing stability for individuals facing mood fluctuations.
  • Research in Neuropharmacology: Researchers study its mechanisms of action to better understand how it affects neurotransmitter systems, contributing to the development of new psychiatric medications.
  • Formulation Development: Pharmaceutical companies utilize ziprasidone hydrochloride monohydrate in developing various dosage forms, including oral capsules and injectable solutions, ensuring versatility in patient treatment options.
  • Comparative Effectiveness Studies: It serves as a benchmark in studies comparing the efficacy and safety of newer antipsychotic agents, helping clinicians make informed treatment decisions.

Citations